Dove

Manufacturer
Conopco Inc. d/b/a Unilever | Unilever Raeford HPCNA
Effective date
2014-10-22
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 22:40:37

Label at a glance#

ProductDove Revive Antiperspirant and Deodorant
Active ingredientAluminum Zirconium Tetrachlorohydrex GLY
Label structure13 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient

Aluminum Zirconium Tetrachlorohydrex GLY (15.2%)

OTC - PURPOSE SECTION

Purpose
anti-perspirant

INDICATIONS & USAGE SECTION

Uses · reduces underarm wetness   · 48 hour protection

WARNINGS SECTION

Warnings
For External Use Only

OTC - DO NOT USE SECTION

Do not use on broken skin

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have kidney disease

OTC - STOP USE SECTION

Stop use if rash or irritation occurs

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.  If swallowed, get medical help or contact a Poison Control Center right away

DOSAGE & ADMINISTRATION SECTION

Directions  apply to underarms only

INACTIVE INGREDIENT SECTION

Inactive ingredients
Cyclopentasiloxane, Stearyl Alcohol, C12-15 Alkyl Benzoate, PPG-14 Butyl Ether, Hydrogenated Castor Oil, Fragrance (Parfum), Dimethicone, Polyethylene, Helianthus Annuus (Sunflower) Seed Oil, Steareth-100, BHT.

OTC - QUESTIONS SECTION

Questions?

Call toll-free 1-800-761-3683

2.6 oz PDP

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DoveRevivePDPDoveRevivePDP

2.6 oz Twin Sleeve

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DoveRevivetwinsleeveDoveRevivetwinsleeve

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
64942-1214-1DoveRevive Antiperspirant and Deodorant74 g in 1 CONTAINERSTICK743
64942-1214-2DoveRevive Antiperspirant and Deodorant45 g in 1 CONTAINERSTICK453
64942-1214-3DoveRevive Antiperspirant and Deodorant14 g in 1 CONTAINERSTICK143
64942-1214-4DoveRevive Antiperspirant and Deodorant2 in 1 PACKAGESTICK23
64942-1214-5DoveRevive Antiperspirant and Deodorant2 in 1 PACKAGESTICK23

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
64942-1214DOVE REVIVE ANTIPERSPIRANT AND DEODORANT (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) STICK [CONOPCO INC. D/B/A UNILEVER]3Legacy NDC, 5 package rows20141023_4f39ef2d-e5c6-4e9a-9bad-eb80bbfbfa80.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Aluminum Zirconium Tetrachlorohydrex GLYACTIVE INGREDIENT8O386558JE3
Aluminum Zirconium Tetrachlorohydrex GLYACTIVE MOIETY8O386558JE3
ALKYL (C12-15) BENZOATEINACTIVE INGREDIENTA9EJ3J61HQ3
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171K3
CYCLOMETHICONE 5INACTIVE INGREDIENT0THT5PCI0R3
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1O3
HIGH DENSITY POLYETHYLENEINACTIVE INGREDIENTUG00KM4WR73
HYDROGENATED CASTOR OILINACTIVE INGREDIENTZF94AP8MEY3
PPG-14 Butyl EtherINACTIVE INGREDIENTR199TJT95T3
STEARETH-100INACTIVE INGREDIENT4OH5W9UM873
Stearyl AlcoholINACTIVE INGREDIENT2KR89I4H1Y3
SUNFLOWER OILINACTIVE INGREDIENT3W1JG795YI3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
64942-121464942-1214-1, 64942-1214-4, 64942-1214-5, 64942-1214-2, 64942-1214-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 2 of 2 · 79 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
CYCLOMETHICONE 5CYCLOMETHICONE 50THT5PCI0RCREAM, AUGMENTED / TOPICAL260 mgExact identifier — unii candidate
3 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7TABLET, COATED / ORAL25 mgExact identifier — unii candidate
18 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7TABLET, EXTENDED RELEASE / ORAL0.64 mgExact identifier — unii candidate
18 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET, EXTENDED RELEASE / ORAL1 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET / SUBLINGUAL0.13 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KSPRAY, METERED / NASAL0.1 mg/1mlExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KINJECTION, SOLUTION / INTRAVENOUSNAExact identifier — unii candidate
32 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7SUPPOSITORY / RECTALNAExact identifier — unii candidate
18 equally ranked IID candidates
Stearyl AlcoholSTEARYL ALCOHOL2KR89I4H1YLOTION / TOPICAL1140 mgExact identifier — unii candidate
12 equally ranked IID candidates
Stearyl AlcoholSTEARYL ALCOHOL2KR89I4H1YTABLET, EXTENDED RELEASE / ORAL244 mgExact identifier — unii candidate
12 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KGEL, METERED / TOPICAL4 mgExact identifier — unii candidate
32 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7CAPSULE / ORAL10 mgExact identifier — unii candidate
18 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7CREAM / TOPICAL54.5 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
HYDROGENATED CASTOR OILHYDROGENATED CASTOR OILZF94AP8MEYCAPSULE / ORAL405 mgExact identifier — unii candidate
12 equally ranked IID candidates
HYDROGENATED CASTOR OILHYDROGENATED CASTOR OILZF94AP8MEYSUSPENSION / TOPICAL286 mgExact identifier — unii candidate
12 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KINJECTION / INTRAVENOUSNAExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET, FOR SUSPENSION / ORAL0.1 mgExact identifier — unii candidate
32 equally ranked IID candidates
HIGH DENSITY POLYETHYLENEHIGH DENSITY POLYETHYLENEUG00KM4WR7SYSTEM / TRANSDERMALNAExact identifier — unii candidate
18 equally ranked IID candidates
HYDROGENATED CASTOR OILHYDROGENATED CASTOR OILZF94AP8MEYTABLET, FOR SUSPENSION / ORAL17 mgExact identifier — unii candidate
12 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4a7c7b27-b503-4870-80fe-97e44482e0af4f39ef2d-e5c6-4e9a-9bad-eb80bbfbfa802014-10-22WarningsExact identifier
spl id: 4a7c7b27-b503-4870-80fe-97e44482e0af
spl set id: 4f39ef2d-e5c6-4e9a-9bad-eb80bbfbfa80

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.